| 1 | compared | 163,556 |
| 2 | .compared | 24 |
| 3 | pared | 10 |
| 4 | bined | 5 |
| 5 | -distribution | 3 |
| 6 | co-dosed | 3 |
| 7 | co-presented | 3 |
| 8 | puddings | 3 |
| 9 | recombines | 3 |
| 10 | -1,3,4-thiadiazol-2-amine | 2 |
| 11 | -compared | 2 |
| 12 | .packing | 2 |
| 13 | acrylo-nitrile | 2 |
| 14 | asociated | 2 |
| 15 | good-response | 2 |
| 16 | hpv-triage | 2 |
| 17 | nano-dots | 2 |
| 18 | wielded | 2 |
| 19 | 'orgasm | 1 |
| 20 | -1,2,4-triazole-3-thione | 1 |
| 21 | -1,2-benzisothiazole | 1 |
| 22 | -1,3,4-thia-diazol-2-amine | 1 |
| 23 | -1,3,6,9-tetraenes | 1 |
| 24 | -1,3-dihydro-4,5-dimethyl-2h-imidazol-2-ylidene | 1 |
| 25 | -1,3-pentadiene | 1 |
| 26 | -1-oh-mc/hsult1b1 | 1 |
| 27 | -1-phenyl-1h-pyrazole-4-carbaldehyde | 1 |
| 28 | -2,4,6-nonatrienal | 1 |
| 29 | -3,6,9,11-tetraenes | 1 |
| 30 | -3-oxoprop-1-en-1-olate | 1 |
| 31 | -4-aryl-3-cyano-6-oxo-1,4,5,6-tetrahydropyridin-2-thiolates | 1 |
| 32 | -6-r-1,2,4-triazin-5-ones | 1 |
| 33 | -anova | 1 |
| 34 | -diastereomer | 1 |
| 35 | -egfr | 1 |
| 36 | -hsct | 1 |
| 37 | -hydroxyethyldiethylenetriamine | 1 |
| 38 | -merocyanine | 1 |
| 39 | -n-carbamoylmethionines | 1 |
| 40 | -ncp | 1 |
| 41 | -ph-box | 1 |
| 42 | -phenyldibromoborane | 1 |
| 43 | -receptor-blockade | 1 |
| 44 | -simultaneously | 1 |
| 45 | -spirocholestane-3,1'-cyclobutane | 1 |
| 46 | -tetraenes | 1 |
| 47 | -ß-cyclodextrin | 1 |
| 48 | .compliance | 1 |
| 49 | .ga | 1 |
| 50 | .pcb | 1 |
| 51 | .relapse | 1 |
| 52 | .veterans | 1 |
| 53 | /1681 | 1 |
| 54 | /d13s319 | 1 |
| 55 | /dp40 | 1 |
| 56 | /ritonavir | 1 |
| 57 | 0.57-2.70 | 1 |
| 58 | 1-fp | 1 |
| 59 | 15.6k | 1 |
| 60 | 2-oxybutynin | 1 |
| 61 | 2-patients | 1 |
| 62 | 2-pyrh | 1 |
| 63 | 2-pyrna | 1 |
| 64 | 26× | 1 |
| 65 | =0.9721 | 1 |
| 66 | =176.07 | 1 |
| 67 | =docox | 1 |
| 68 | a1compared | 1 |
| 69 | amino-3-allylglycerol | 1 |
| 70 | antiferromagnets | 1 |
| 71 | apge | 1 |
| 72 | arylether | 1 |
| 73 | assonated | 1 |
| 74 | assyed | 1 |
| 75 | bead™ | 1 |
| 76 | c-ndma | 1 |
| 77 | catemers | 1 |
| 78 | co-digesting | 1 |
| 79 | co-polymerized | 1 |
| 80 | co-pyrolyzed | 1 |
| 81 | commensurable | 1 |
| 82 | comparted | 1 |
| 83 | complicit | 1 |
| 84 | coterminated | 1 |
| 85 | coterminating | 1 |
| 86 | crossreacted | 1 |
| 87 | fmmm | 1 |
| 88 | follow-up.compared | 1 |
| 89 | frequency/days | 1 |
| 90 | gestoden | 1 |
| 91 | i-patients | 1 |
| 92 | iii-patients | 1 |
| 93 | interplayed | 1 |
| 94 | journeying | 1 |
| 95 | ketoimines | 1 |
| 96 | levels-compared | 1 |
| 97 | micro-aggregates | 1 |
| 98 | naloxone-appropriate-responding | 1 |
| 99 | neuro-worsening | 1 |
| 100 | ofdexmedetomidine | 1 |
| 101 | parison | 1 |
| 102 | participants.individuals | 1 |
| 103 | pent-3-en-1-ol | 1 |
| 104 | podlech | 1 |
| 105 | preabsorbed | 1 |
| 106 | prehydrolyzed | 1 |
| 107 | preoxygenating | 1 |
| 108 | propanol-1 | 1 |
| 109 | proteo-ligands | 1 |
| 110 | r-3 | 1 |
| 111 | relative-compared | 1 |
| 112 | rigation | 1 |
| 113 | rs7579 | 1 |
| 114 | semicircles | 1 |
| 115 | specificity.patients | 1 |
| 116 | tc-labeling | 1 |
| 117 | treatreatment | 1 |
| 118 | tribenzoporphyrazine | 1 |
| 119 | ·h·l | 1 |
| 120 | ß-tricalcium-phosphate-particles | 1 |
| 121 | ⋅en | 1 |
| 1 | 'orgasm | 1 |
| 2 | -1,2,4-triazole-3-thione | 1 |
| 3 | -1,2-benzisothiazole | 1 |
| 4 | -1,3,4-thia-diazol-2-amine | 1 |
| 5 | -1,3,4-thiadiazol-2-amine | 2 |
| 6 | -1,3,6,9-tetraenes | 1 |
| 7 | -1,3-dihydro-4,5-dimethyl-2h-imidazol-2-ylidene | 1 |
| 8 | -1,3-pentadiene | 1 |
| 9 | -1-oh-mc/hsult1b1 | 1 |
| 10 | -1-phenyl-1h-pyrazole-4-carbaldehyde | 1 |
| 11 | -2,4,6-nonatrienal | 1 |
| 12 | -3,6,9,11-tetraenes | 1 |
| 13 | -3-oxoprop-1-en-1-olate | 1 |
| 14 | -4-aryl-3-cyano-6-oxo-1,4,5,6-tetrahydropyridin-2-thiolates | 1 |
| 15 | -6-r-1,2,4-triazin-5-ones | 1 |
| 16 | -anova | 1 |
| 17 | -compared | 2 |
| 18 | -diastereomer | 1 |
| 19 | -distribution | 3 |
| 20 | -egfr | 1 |
| 21 | -hsct | 1 |
| 22 | -hydroxyethyldiethylenetriamine | 1 |
| 23 | -merocyanine | 1 |
| 24 | -n-carbamoylmethionines | 1 |
| 25 | -ncp | 1 |
| 26 | -ph-box | 1 |
| 27 | -phenyldibromoborane | 1 |
| 28 | -receptor-blockade | 1 |
| 29 | -simultaneously | 1 |
| 30 | -spirocholestane-3,1'-cyclobutane | 1 |
| 31 | -tetraenes | 1 |
| 32 | -ß-cyclodextrin | 1 |
| 33 | .compared | 24 |
| 34 | .compliance | 1 |
| 35 | .ga | 1 |
| 36 | .packing | 2 |
| 37 | .pcb | 1 |
| 38 | .relapse | 1 |
| 39 | .veterans | 1 |
| 40 | /1681 | 1 |
| 41 | /d13s319 | 1 |
| 42 | /dp40 | 1 |
| 43 | /ritonavir | 1 |
| 44 | 0.57-2.70 | 1 |
| 45 | 1-fp | 1 |
| 46 | 15.6k | 1 |
| 47 | 2-oxybutynin | 1 |
| 48 | 2-patients | 1 |
| 49 | 2-pyrh | 1 |
| 50 | 2-pyrna | 1 |
| 51 | 26× | 1 |
| 52 | =0.9721 | 1 |
| 53 | =176.07 | 1 |
| 54 | =docox | 1 |
| 55 | a1compared | 1 |
| 56 | acrylo-nitrile | 2 |
| 57 | amino-3-allylglycerol | 1 |
| 58 | antiferromagnets | 1 |
| 59 | apge | 1 |
| 60 | arylether | 1 |
| 61 | asociated | 2 |
| 62 | assonated | 1 |
| 63 | assyed | 1 |
| 64 | bead™ | 1 |
| 65 | bined | 5 |
| 66 | c-ndma | 1 |
| 67 | catemers | 1 |
| 68 | co-digesting | 1 |
| 69 | co-dosed | 3 |
| 70 | co-polymerized | 1 |
| 71 | co-presented | 3 |
| 72 | co-pyrolyzed | 1 |
| 73 | commensurable | 1 |
| 74 | compared | 163,556 |
| 75 | comparted | 1 |
| 76 | complicit | 1 |
| 77 | coterminated | 1 |
| 78 | coterminating | 1 |
| 79 | crossreacted | 1 |
| 80 | fmmm | 1 |
| 81 | follow-up.compared | 1 |
| 82 | frequency/days | 1 |
| 83 | gestoden | 1 |
| 84 | good-response | 2 |
| 85 | hpv-triage | 2 |
| 86 | i-patients | 1 |
| 87 | iii-patients | 1 |
| 88 | interplayed | 1 |
| 89 | journeying | 1 |
| 90 | ketoimines | 1 |
| 91 | levels-compared | 1 |
| 92 | micro-aggregates | 1 |
| 93 | naloxone-appropriate-responding | 1 |
| 94 | nano-dots | 2 |
| 95 | neuro-worsening | 1 |
| 96 | ofdexmedetomidine | 1 |
| 97 | pared | 10 |
| 98 | parison | 1 |
| 99 | participants.individuals | 1 |
| 100 | pent-3-en-1-ol | 1 |
| 101 | podlech | 1 |
| 102 | preabsorbed | 1 |
| 103 | prehydrolyzed | 1 |
| 104 | preoxygenating | 1 |
| 105 | propanol-1 | 1 |
| 106 | proteo-ligands | 1 |
| 107 | puddings | 3 |
| 108 | r-3 | 1 |
| 109 | recombines | 3 |
| 110 | relative-compared | 1 |
| 111 | rigation | 1 |
| 112 | rs7579 | 1 |
| 113 | semicircles | 1 |
| 114 | specificity.patients | 1 |
| 115 | tc-labeling | 1 |
| 116 | treatreatment | 1 |
| 117 | tribenzoporphyrazine | 1 |
| 118 | wielded | 2 |
| 119 | ·h·l | 1 |
| 120 | ß-tricalcium-phosphate-particles | 1 |
| 121 | ⋅en | 1 |
| 1 | /dp40 | 1 |
| 2 | 0.57-2.70 | 1 |
| 3 | propanol-1 | 1 |
| 4 | =0.9721 | 1 |
| 5 | /1681 | 1 |
| 6 | -1-oh-mc/hsult1b1 | 1 |
| 7 | r-3 | 1 |
| 8 | =176.07 | 1 |
| 9 | /d13s319 | 1 |
| 10 | rs7579 | 1 |
| 11 | .ga | 1 |
| 12 | c-ndma | 1 |
| 13 | 2-pyrna | 1 |
| 14 | -anova | 1 |
| 15 | .pcb | 1 |
| 16 | preabsorbed | 1 |
| 17 | wielded | 2 |
| 18 | bined | 5 |
| 19 | pared | 10 |
| 20 | compared | 163,556 |
| 21 | -compared | 2 |
| 22 | relative-compared | 1 |
| 23 | levels-compared | 1 |
| 24 | .compared | 24 |
| 25 | follow-up.compared | 1 |
| 26 | a1compared | 1 |
| 27 | co-dosed | 3 |
| 28 | asociated | 2 |
| 29 | coterminated | 1 |
| 30 | assonated | 1 |
| 31 | crossreacted | 1 |
| 32 | co-presented | 3 |
| 33 | comparted | 1 |
| 34 | interplayed | 1 |
| 35 | assyed | 1 |
| 36 | co-polymerized | 1 |
| 37 | prehydrolyzed | 1 |
| 38 | co-pyrolyzed | 1 |
| 39 | .compliance | 1 |
| 40 | -receptor-blockade | 1 |
| 41 | -1-phenyl-1h-pyrazole-4-carbaldehyde | 1 |
| 42 | hpv-triage | 2 |
| 43 | apge | 1 |
| 44 | commensurable | 1 |
| 45 | acrylo-nitrile | 2 |
| 46 | -1,2-benzisothiazole | 1 |
| 47 | -phenyldibromoborane | 1 |
| 48 | -spirocholestane-3,1'-cyclobutane | 1 |
| 49 | -1,3-dihydro-4,5-dimethyl-2h-imidazol-2-ylidene | 1 |
| 50 | -1,3-pentadiene | 1 |
| 51 | ofdexmedetomidine | 1 |
| 52 | -1,3,4-thia-diazol-2-amine | 1 |
| 53 | -1,3,4-thiadiazol-2-amine | 2 |
| 54 | -hydroxyethyldiethylenetriamine | 1 |
| 55 | -merocyanine | 1 |
| 56 | tribenzoporphyrazine | 1 |
| 57 | -1,2,4-triazole-3-thione | 1 |
| 58 | good-response | 2 |
| 59 | .relapse | 1 |
| 60 | -3-oxoprop-1-en-1-olate | 1 |
| 61 | naloxone-appropriate-responding | 1 |
| 62 | .packing | 2 |
| 63 | tc-labeling | 1 |
| 64 | neuro-worsening | 1 |
| 65 | preoxygenating | 1 |
| 66 | coterminating | 1 |
| 67 | co-digesting | 1 |
| 68 | journeying | 1 |
| 69 | podlech | 1 |
| 70 | 2-pyrh | 1 |
| 71 | 15.6k | 1 |
| 72 | -2,4,6-nonatrienal | 1 |
| 73 | pent-3-en-1-ol | 1 |
| 74 | amino-3-allylglycerol | 1 |
| 75 | ·h·l | 1 |
| 76 | fmmm | 1 |
| 77 | 'orgasm | 1 |
| 78 | gestoden | 1 |
| 79 | ⋅en | 1 |
| 80 | 2-oxybutynin | 1 |
| 81 | -ß-cyclodextrin | 1 |
| 82 | rigation | 1 |
| 83 | -distribution | 3 |
| 84 | parison | 1 |
| 85 | -ncp | 1 |
| 86 | 1-fp | 1 |
| 87 | arylether | 1 |
| 88 | -diastereomer | 1 |
| 89 | -egfr | 1 |
| 90 | /ritonavir | 1 |
| 91 | proteo-ligands | 1 |
| 92 | ß-tricalcium-phosphate-particles | 1 |
| 93 | semicircles | 1 |
| 94 | -tetraenes | 1 |
| 95 | -3,6,9,11-tetraenes | 1 |
| 96 | -1,3,6,9-tetraenes | 1 |
| 97 | recombines | 3 |
| 98 | ketoimines | 1 |
| 99 | -n-carbamoylmethionines | 1 |
| 100 | -6-r-1,2,4-triazin-5-ones | 1 |
| 101 | micro-aggregates | 1 |
| 102 | -4-aryl-3-cyano-6-oxo-1,4,5,6-tetrahydropyridin-2-thiolates | 1 |
| 103 | puddings | 3 |
| 104 | participants.individuals | 1 |
| 105 | .veterans | 1 |
| 106 | catemers | 1 |
| 107 | antiferromagnets | 1 |
| 108 | 2-patients | 1 |
| 109 | i-patients | 1 |
| 110 | iii-patients | 1 |
| 111 | specificity.patients | 1 |
| 112 | nano-dots | 2 |
| 113 | frequency/days | 1 |
| 114 | -hsct | 1 |
| 115 | complicit | 1 |
| 116 | treatreatment | 1 |
| 117 | -ph-box | 1 |
| 118 | =docox | 1 |
| 119 | -simultaneously | 1 |
| 120 | 26× | 1 |
| 121 | bead™ | 1 |